![Joan Manthis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joan Manthis
Corporate Officer/Principal chez Bausch & Lomb (Australia) Pty Ltd.
Postes actifs de Joan Manthis
Sociétés | Poste | Début | Fin |
---|---|---|---|
Bausch & Lomb (Australia) Pty Ltd.
![]() Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia. | Corporate Officer/Principal | 06/06/2011 | - |
Historique de carrière de Joan Manthis
Anciens postes connus de Joan Manthis
Sociétés | Poste | Début | Fin |
---|---|---|---|
Euthymics Bioscience, Inc.
![]() Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 19/08/2010 | - |
Medtronic Trading Ltd. | Corporate Officer/Principal | - | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
MGI PHARMA Biologics, Inc.
![]() MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Sales & Marketing | - | - |
OREXIGEN THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Formation de Joan Manthis
University of Minnesota | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Israël | 2 |
Australie | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 1 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Entreprise privées | 5 |
---|---|
Euthymics Bioscience, Inc.
![]() Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Commercial Services |
Orexigen Therapeutics, Inc.
![]() Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
MGI PHARMA Biologics, Inc.
![]() MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Health Technology |
Medtronic Trading Ltd. | |
Bausch & Lomb (Australia) Pty Ltd.
![]() Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia. | Health Technology |
- Bourse
- Insiders
- Joan Manthis
- Expérience